| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.029 | 0.8 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |